Conference Details - Overview
Continuing Education Information
Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
School of Breast Oncology
Emory University Conference Center
Atlanta, GA
November 5-8, 2009
Conference Overview
Over the past decade, an increasing number of oncologists have concentrated their practices on breast cancer. In order to advance patient care, the School of Breast Oncology was developed. This curriculum-based program focuses exclusively on breast cancer clinical management. This intensive 4-day interactive educational course will provide a comprehensive review of the existing data on the most important aspects of breast cancer biology, diagnostics, prevention, and treatment. The curriculum will be evidence based, summarizing the existing data for each topic and applying these data to patient cases.
Follow us on Twitter @SOBO2009
www.twitter.com/SOBO2009
This educational program is directed toward medical, radiation, and surgical oncologists whose primary practice focus is breast cancer and who intend to reinforce their knowledge base and expand their expertise in breast cancer diagnosis, treatment, and management. Participants will be primarily oncologists or fellows in training whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of breast cancer.
At the conclusion of this school, you should be able to:
- Discuss breast carcinogenesis and the impact of germline mutations on patient management
- Explain the clinical utility and limitations of sentinel lymph node biopsy
- Integrate current staging guidelines into clinical decision making regarding local and systemic therapies
- Discuss advances in breast cancer imaging and early detection, including mammography, ultrasound, MRI, and PET scanning
- Integrate prognostic and predictive factors for breast cancer into patient management decisions and assess the optimal means of HER2 and hormone receptor expression analysis
- Assess optimal radiation therapy strategies for treatment of patients with DCIS, early-stage, and locally advanced breast cancer
- Critically analyze the data guiding the choice of adjuvant chemotherapies, endocrine therapies, or targeted agents for patients with low- and high-risk breast cancer and for elderly patients
- Evaluate the evidence guiding treatment recommendations for the management of patients with hormone-dependent and hormone-independent metastatic breast cancer
- Evaluate organ-specific therapeutic interventions for patients with metastatic disease to the CNS and skeleton
- Integrate palliative care strategies into treatment algorithms for metastatic disease
- List novel chemotherapies and targeted agents currently under evaluation for the treatment of advanced and early-stage breast cancer
- Describe current and emerging strategies for ameliorating or eliminating therapy-associated adverse events
- Assess the evidence supporting an emphasis on quality of life and rehabilitation during and after breast cancer treatment
- Refer appropriate patients to promising clinical trials
Educational Grants
An educational grant for this activity was provided by:
- Genentech BioOncology
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- Novartis Oncology